$1.56
0.1510.64%
At Close: -
$1.56
00.00%
After Hours: Aug 23, 4:00 PM EDT
15 minutes delayed
Mersana Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Mersana Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.20 | $-0.17 | -17.6 % |
Mar 2024 | 2024-05-09 | $-0.16 | $-0.18 | 11.1 % |
Dec 2023 | 2024-02-28 | $-0.16 | $-0.16 | 0.00 % |
Sep 2023 | 2023-11-07 | $-0.35 | $-0.36 | 2.78 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $2.29M | $9.13M | -74.9 % |
Mar 2024 | 2024-05-09 | $9.24M | $8.50M | 8.76 % |
Dec 2023 | 2024-02-28 | $10.70M | $14.77M | -27.6 % |
Sep 2023 | 2023-11-07 | $7.70M | $9.35M | -17.7 % |
Mersana Therapeutics (MRSN) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.20, which missed the estimate of $-0.17.
The Actual Revenue was $2.3M, which missed the estimate of $9.1M.
Browse earnings estimates, EPS, and revenue on all stocks.